tirzepatide and mental health reduces food intake appetite, and affects brain functioning, more than placebo and liraglutide Tirzepatide: A breakthrough for obesity,

But these health issues may raise your risk: Diabetes High blood pressure High cholesterol Obstructive sleep apnea Taking certain medications (PDE4 inhibitors) Smoking Eye problems that can increase your risk include: Previous NAION in one eye A naturally crowded optic nerve (called disk at risk) Having prior eye surgery You can still take semaglutide or other GLP-1 drugs if you have these conditions

The first week is about your body adjusting to the medication

A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association between a medicine and an adverse event that warrants further investigation

Convenience: Administered once weekly, making it easier to adhere to compared to daily medications

Semaglutide is distinguished from native GLP-1 by three modifications

Additionally, differences in CCL2 levels in serum or CSF have been associated with different clinical subtypes of PD